148 related articles for article (PubMed ID: 10407062)
1. Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye.
Farboud B; Aotaki-Keen A; Miyata T; Hjelmeland LM; Handa JT
Mol Vis; 1999 Jul; 5():11. PubMed ID: 10407062
[TBL] [Abstract][Full Text] [Related]
2. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Choi YG; Lim S
J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
6. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas.
Yamada Y; Ishibashi K; Ishibashi K; Bhutto IA; Tian J; Lutty GA; Handa JT
Exp Eye Res; 2006 May; 82(5):840-8. PubMed ID: 16364296
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
[TBL] [Abstract][Full Text] [Related]
8. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.
Glenn JV; Beattie JR; Barrett L; Frizzell N; Thorpe SR; Boulton ME; McGarvey JJ; Stitt AW
FASEB J; 2007 Nov; 21(13):3542-52. PubMed ID: 17567569
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".
Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B
Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175
[TBL] [Abstract][Full Text] [Related]
10. The glycation of fibronectin by glycolaldehyde and methylglyoxal as a model for aging in Bruch's membrane.
Thao MT; Gaillard ER
Amino Acids; 2016 Jul; 48(7):1631-9. PubMed ID: 27084712
[TBL] [Abstract][Full Text] [Related]
11. Modifications to the basement membrane protein laminin using glycolaldehyde and A2E: a model for aging in Bruch's membrane.
Murdaugh LS; Dillon J; Gaillard ER
Exp Eye Res; 2009 Aug; 89(2):187-92. PubMed ID: 19358843
[TBL] [Abstract][Full Text] [Related]
12. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
[TBL] [Abstract][Full Text] [Related]
13. ELISA of pentosidine, an advanced glycation end product, in biological specimens.
Taneda S; Monnier VM
Clin Chem; 1994 Sep; 40(9):1766-73. PubMed ID: 8070089
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
[TBL] [Abstract][Full Text] [Related]
15. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
16. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
17. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.
Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R
J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354
[TBL] [Abstract][Full Text] [Related]
18. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
19. An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages.
Mera K; Nagai R; Takeo K; Izumi M; Maruyama T; Otagiri M
Biochem Biophys Res Commun; 2011 Apr; 407(2):420-5. PubMed ID: 21402053
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]